New NO-releasing pharmacodynamic hybrids of losartan and its active metabolite: design, synthesis, and biopharmacological properties

…, V Calderone, M Digiacomo, M Macchia…

Index: Breschi, Maria C.; Calderone, Vincenzo; Digiacomo, Maria; Macchia, Marco; Martelli, Alma; Martinotti, Enrica; Minutolo, Filippo; Rapposelli, Simona; Rossello, Armando; Testai, Lara; Balsamo, Aldo Journal of Medicinal Chemistry, 2006 , vol. 49, # 8 p. 2628 - 2639

Full Text: HTML

Citation Number: 55

Abstract

In a preliminary work, we reported two NO-sartans, possessing the characteristics of an AT1 antagonist and a “slow NO donor”, obtained by adding NO-donor side chains to losartan 1. The NO release from an NO-sartan should be modulated in order to strengthen the antihypertensive activity of the native drug and to ensure additional effects, such as the antiplatelet and anti-ischemic ones. To obtain a collection of prototypical NO-sartans, ...